Importantly, the in silico results obtained using our next generation knowledge discovery pipeline coupled with xMAP assay also showed a potential association of S1P in asthma and other respiratory diseases which is detrimental for the patients due to its ability to trigger an array of cytokines, chemokines, and growth factors. The gene discussed is MBTPS1; the disease is respiratory system disorder.